LEK PHARMACEUTICALS D.D.
Patent Owner
Stats
- 66 US PATENTS IN FORCE
- 5 US APPLICATIONS PENDING
- Mar 06, 2018 most recent publication
Details
- 66 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 473 Total Citation Count
- Jun 09, 2000 Earliest Filing
- 113 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0321,288 Predicting Productivity In Early Cell Line DevelopmentNov 12, 15Nov 09, 17[C12Q, C12P, C12N, C07K]
2017/0314,082 Predicting Genetically Stable Recombinant Protein Production In Early Cell Line DevelopmentNov 12, 15Nov 02, 17[C12Q, C12N]
2017/0258,726 Spray-Freeze Drying of Polyelectrolyte Nanoparticles Containing the Protein DrugSep 18, 15Sep 14, 17[A61K]
2016/0346,207 Solid Pharmaceutical Compositions Of Androgen Receptor AntagonistsFeb 04, 15Dec 01, 16[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9732053 1-[2-(2,4-dimethylphenylsulfanyl) phenyl]piperazine acetate in crystalline formJun 30, 14Aug 15, 17[C07D, C07C]
9637769 Reduction of formation of amidated amino acids in cell lines for protein expressionApr 16, 13May 02, 17[C12P, C12N]
9562082 Production of glycoproteins with low N-glycolylneuraminic acid (Neu5Gc) contentMay 16, 14Feb 07, 17[C12P, C12N, C07K]
9512097 Process for the preparation of 3-aroyl-5-aminobenzofuran derivativesNov 11, 11Dec 06, 16[A61K, C07D]
9499857 Selection of triploid CHO cells and cell lines expressing recombinant polypeptides as high producersNov 09, 11Nov 22, 16[C12Q, C12P, C12N]
9493409 Process for the synthesis of 1-(2-((2,4-dimethylphenyl)thio)phenyl)piperazineApr 04, 14Nov 15, 16[C07D, C07C]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0194,680 Enzymatic Route For The Preparation Of Chiral Gamma-Aryl-Beta-Aminobutyric Acid DerivativesAbandonedDec 20, 13Jul 07, 16[A61K, C12P, C07C]
2014/0044,783 PHARMACEUTICAL COMPOSITION COMPRISING A THIAZOLIDINEDIONEAbandonedOct 07, 11Feb 13, 14[A61K]
8614331 Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodiumExpiredJul 08, 09Dec 24, 13[C07D]
2013/0337,485 ENZYMATIC SYNTHESIS OF ACTIVE PHARMACEUTICAL INGREDIENT AND INTERMEDIATES THEREOFAbandonedDec 20, 11Dec 19, 13[C12P]
2013/0259,935 PHARMACEUTICAL COMPOSITIONS COMPRISING GLIMEPIRIDE AND POLYETHYLENE GLYCOL CASTOR OILAbandonedOct 07, 11Oct 03, 13[A61K]
2013/0202,713 COATING OF PARTICLES COMPRISING A PHARMACEUTICALLY ACTIVE INGREDIENT WITH A CARBONATE SALT OR PHOSPHATE SALTAbandonedDec 20, 10Aug 08, 13[A61J, A61K]
8445693 Catalyzed carbonylation in the synthesis of angiotensin II antagonistsExpiredMar 19, 09May 21, 13[C07D]
2013/0115,301 COATING OF PARTICLES COMPRISING A PHARMACEUTICALLY ACTIVE INGREDIENT WITH A CARBONATE SALT OR PHOSPHATE SALTAbandonedDec 20, 10May 09, 13[A61K]
8410285 2′-halobiphenyl-4-yl intermediates in the synthesis of angiotensin II antagonistsExpiredMar 19, 09Apr 02, 13[C07D]
8362259 Process for the preparation of esomeprazole magnesium in a stable formExpiredJul 21, 09Jan 29, 13[C07D]
2012/0149,895 PROCESS FOR DIMETHYLATION OF ACTIVE METHYLENE GROUPSAbandonedMar 30, 10Jun 14, 12[C07D, C07C]
2012/0087,953 PHARMACEUTICAL COMPOSITIONS OF ACTIVE PHARMACEUTICAL INGREDIENT COMPRISING SULPHONYLUREA MOIETY WITH EXCELLENT DISSOLUTION PROPERTIESAbandonedMar 03, 10Apr 12, 12[A61J, A61K]
2012/0088,774 ACTIVE PHARMACEUTICAL INGREDIENT ADSORBED ON SOLID SUPPORTAbandonedApr 06, 10Apr 12, 12[A61K, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.